Ggjj, I haven't got a clue what will make this run. Today's volume showed it could run real quick with the right announcement.
They have 4 undisclosed projects that we have no timetable on. Two projects with Novartis and CSL that could come out Of the blue.
Who knows. I know the chances of success and value of OXYPATCH. So I am staying put. If it takes another year, so be it.
It is hard to overstate what the success of OXYPATCH trials mean to this company.
PoS
phosphagenics collaborates with 3m to develop , page-39
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $973 | 486.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 6361102 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 41925822 | 29 |
View Market Depth
| Last trade - 10.27am 31/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |